These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16039613)

  • 1. Dynamic regulation of molecular chaperone gene expression in polyglutamine disease.
    Huen NY; Chan HY
    Biochem Biophys Res Commun; 2005 Sep; 334(4):1074-84. PubMed ID: 16039613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased expression of Hsp27 and Hsp70 in transformed lymphoblastoid cells from patients with spinocerebellar ataxia type 7.
    Tsai HF; Lin SJ; Li C; Hsieh M
    Biochem Biophys Res Commun; 2005 Sep; 334(4):1279-86. PubMed ID: 16039988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of chaperone suppression of polyglutamine disease: selectivity, synergy and modulation of protein solubility in Drosophila.
    Chan HY; Warrick JM; Gray-Board GL; Paulson HL; Bonini NM
    Hum Mol Genet; 2000 Nov; 9(19):2811-20. PubMed ID: 11092757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of genes that modify ataxin-1-induced neurodegeneration.
    Fernandez-Funez P; Nino-Rosales ML; de Gouyon B; She WC; Luchak JM; Martinez P; Turiegano E; Benito J; Capovilla M; Skinner PJ; McCall A; Canal I; Orr HT; Zoghbi HY; Botas J
    Nature; 2000 Nov; 408(6808):101-6. PubMed ID: 11081516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expanded polyglutamine domain possesses nuclear export activity which modulates subcellular localization and toxicity of polyQ disease protein via exportin-1.
    Chan WM; Tsoi H; Wu CC; Wong CH; Cheng TC; Li HY; Lau KF; Shaw PC; Perrimon N; Chan HY
    Hum Mol Genet; 2011 May; 20(9):1738-50. PubMed ID: 21300695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70.
    Warrick JM; Chan HY; Gray-Board GL; Chai Y; Paulson HL; Bonini NM
    Nat Genet; 1999 Dec; 23(4):425-8. PubMed ID: 10581028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pathogenic agent in Drosophila models of 'polyglutamine' diseases.
    McLeod CJ; O'Keefe LV; Richards RI
    Hum Mol Genet; 2005 Apr; 14(8):1041-8. PubMed ID: 15757976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for sequestration of polyglutamine inclusions by Drosophila myeloid leukemia factor.
    Kim WY; Fayazi Z; Bao X; Higgins D; Kazemi-Esfarjani P
    Mol Cell Neurosci; 2005 Aug; 29(4):536-44. PubMed ID: 15936212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurodegeneration in the polyglutamine diseases: Act 1, Scene 1.
    Nussbaum R; Auburger G
    Nat Neurosci; 2000 Feb; 3(2):103-4. PubMed ID: 10649562
    [No Abstract]   [Full Text] [Related]  

  • 10. Interference of CREB-dependent transcriptional activation by expanded polyglutamine stretches--augmentation of transcriptional activation as a potential therapeutic strategy for polyglutamine diseases.
    Shimohata M; Shimohata T; Igarashi S; Naruse S; Tsuji S
    J Neurochem; 2005 May; 93(3):654-63. PubMed ID: 15836624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyglutamine diseases and molecular chaperones.
    Kimura Y; Kakizuka A
    IUBMB Life; 2003 Jun; 55(6):337-45. PubMed ID: 12938736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel mechanism of Hsp70 chaperone-mediated prevention of polyglutamine aggregates in a cellular model of huntington disease.
    Guzhova IV; Lazarev VF; Kaznacheeva AV; Ippolitova MV; Muronetz VI; Kinev AV; Margulis BA
    Hum Mol Genet; 2011 Oct; 20(20):3953-63. PubMed ID: 21775503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hosting neurotoxicity in polyglutamine disease.
    Liu N; Bonini NM
    Cell; 2006 Dec; 127(7):1299-300. PubMed ID: 17190592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bax-like protein Drob-1 protects neurons from expanded polyglutamine-induced toxicity in Drosophila.
    Senoo-Matsuda N; Igaki T; Miura M
    EMBO J; 2005 Jul; 24(14):2700-13. PubMed ID: 16001086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of heat shock proteins Hsp70 and Hsp27 in cellular protection of the central nervous system.
    Franklin TB; Krueger-Naug AM; Clarke DB; Arrigo AP; Currie RW
    Int J Hyperthermia; 2005 Aug; 21(5):379-92. PubMed ID: 16048836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phage display screening for peptides that inhibit polyglutamine aggregation.
    Kenan DJ; Strittmatter WJ; Burke JR
    Methods Enzymol; 2006; 413():253-73. PubMed ID: 17046401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of ter94, Drosophila VCP, as a modulator of polyglutamine-induced neurodegeneration.
    Higashiyama H; Hirose F; Yamaguchi M; Inoue YH; Fujikake N; Matsukage A; Kakizuka A
    Cell Death Differ; 2002 Mar; 9(3):264-73. PubMed ID: 11859409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional alterations and chromatin remodeling in polyglutamine diseases.
    Helmlinger D; Tora L; Devys D
    Trends Genet; 2006 Oct; 22(10):562-70. PubMed ID: 16911843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut myoelectrical activity induces heat shock response in Escherichia coli and Caco-2 cells.
    Laubitz D; Jankowska A; Sikora A; Woliński J; Zabielski R; Grzesiuk E
    Exp Physiol; 2006 Sep; 91(5):867-75. PubMed ID: 16728456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mechanisms of neurodegeneration in polyglutamine diseases].
    Tsuji S
    Rinsho Shinkeigaku; 2003 Nov; 43(11):901-2. PubMed ID: 15152498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.